| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
383,180,000 |
| Market
Cap: |
2.61(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$1.255 - $9.15 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile ImmunityBio is a clinical-stage biotechnology company developing therapies and vaccines that complement, harness, and amplify the immune system to defeat cancers and infectious diseases. Co.'s platforms include: antibody cytokine fusion proteins, which include Anktiva, a class of biopharmaceuticals that enhance the therapeutic potential of cytokines, and promote lymphocyte infiltration at a site of disease, improving immune response; and DNA, RNA, and recombinant protein vaccine technologies, which are for infectious diseases to target viruses, including SARS-CoV-2, and for oncology to deliver common tumor-associated antigens, and neoepitopes (expressed only by cancer cells).
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
103,915 |
103,915 |
| Total Buy Value |
$0 |
$0 |
$289,093 |
$289,093 |
| Total People Bought |
0 |
0 |
3 |
3 |
| Total Buy Transactions |
0 |
0 |
3 |
3 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-22 |
2023-11-21 |
2023-05-23 |
2022-05-23 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Simon Barry J. |
See remarks |
• • – |
2021-02-02 |
4 |
OE |
$2.00 |
$164,009 |
D/D |
82,070 |
3,252,610 |
|
- |
|
| Simon Barry J. |
See remarks |
• • – |
2021-01-28 |
4 |
AS |
$20.53 |
$232,121 |
D/D |
(11,304) |
3,170,540 |
|
-17% |
|
| Simon Barry J. |
See remarks |
• • – |
2021-01-28 |
4 |
OE |
$2.00 |
$22,590 |
D/D |
11,304 |
3,181,844 |
|
- |
|
| Simon Barry J. |
See remarks |
• • – |
2021-01-27 |
4 |
AS |
$20.61 |
$754,946 |
D/D |
(36,626) |
3,170,540 |
|
-21% |
|
| Simon Barry J. |
See remarks |
• • – |
2021-01-27 |
4 |
OE |
$2.00 |
$73,193 |
D/D |
36,626 |
3,207,166 |
|
- |
|
| Nelson Sonja |
Chief Financial Officer |
• – – |
2021-01-12 |
4 |
AS |
$15.00 |
$245,460 |
D/D |
(16,364) |
15,410 |
|
-1% |
|
| Nelson Sonja |
Chief Financial Officer |
• – – |
2021-01-12 |
4 |
OE |
$3.07 |
$34,887 |
D/D |
11,364 |
31,774 |
|
- |
|
| Nelson Sonja |
Chief Financial Officer |
• – – |
2021-01-04 |
4 |
AS |
$13.62 |
$534,938 |
D/D |
(39,271) |
20,410 |
|
5% |
|
| Nelson Sonja |
Chief Financial Officer |
• – – |
2021-01-04 |
4 |
OE |
$3.07 |
$69,778 |
D/D |
22,729 |
59,681 |
|
- |
|
| Simon Barry J. |
See remarks |
• • – |
2020-12-22 |
4 |
AS |
$18.05 |
$2,346,604 |
D/D |
(130,000) |
3,170,540 |
|
-10% |
|
| Simon Barry J. |
See remarks |
• • – |
2020-12-22 |
4 |
OE |
$2.00 |
$259,792 |
D/D |
130,000 |
3,300,540 |
|
- |
|
| Thomas John C |
Director |
– • – |
2020-12-10 |
4 |
AS |
$10.83 |
$461,122 |
D/D |
(42,592) |
207,477 |
|
64% |
|
| Thomas John C |
Director |
– • – |
2020-08-19 |
4 |
S |
$9.19 |
$183,800 |
D/D |
(20,000) |
250,069 |
|
-49% |
|
| Thomas John C |
Director |
– • – |
2020-08-13 |
4 |
S |
$9.34 |
$376,600 |
D/D |
(40,000) |
270,069 |
|
-73% |
|
| Driscoll Frederick W |
Director |
– • – |
2020-08-11 |
4 |
S |
$9.98 |
$668,052 |
D/D |
(65,300) |
109,235 |
|
-86% |
|
| Cohen Cheryl |
Director |
– • – |
2020-08-11 |
4 |
S |
$9.96 |
$298,785 |
D/D |
(30,000) |
270,925 |
|
-86% |
|
| Thomas John C |
Director |
– • – |
2020-08-11 |
4 |
S |
$10.35 |
$207,042 |
D/D |
(20,000) |
310,069 |
|
-86% |
|
| Nelson Sonja |
Chief Financial Officer |
• – – |
2020-08-02 |
4 |
D |
$11.18 |
$38,660 |
D/D |
(3,458) |
36,952 |
|
- |
|
| Nelson Sonja |
Chief Financial Officer |
• – – |
2020-08-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,000 |
40,410 |
|
- |
|
| Simon Barry J. |
See remarks |
• • – |
2020-07-21 |
4 |
AS |
$15.50 |
$24,258 |
D/D |
(1,565) |
3,170,540 |
|
-36% |
|
| Simon Barry J. |
See remarks |
• • – |
2020-07-21 |
4 |
OE |
$2.00 |
$3,127 |
D/D |
1,565 |
3,172,105 |
|
- |
|
| Simon Barry J. |
See remarks |
• • – |
2020-07-20 |
4 |
AS |
$15.53 |
$1,995,071 |
D/D |
(128,435) |
3,170,540 |
|
-38% |
|
| Simon Barry J. |
See remarks |
• • – |
2020-07-20 |
4 |
OE |
$1.76 |
$246,767 |
D/D |
128,435 |
3,298,975 |
|
- |
|
| Simon Barry J. |
See remarks |
• • – |
2020-07-08 |
4 |
AS |
$13.14 |
$524,759 |
D/D |
(39,950) |
3,170,540 |
|
-45% |
|
| Simon Barry J. |
See remarks |
• • – |
2020-07-08 |
4 |
OE |
$1.76 |
$70,128 |
D/D |
39,950 |
3,210,490 |
|
- |
|
195 Records found
|
|
Page 3 of 8 |
|
|
0.24 (3.34%) 
